share_log

美诺华(603538.SH):在抗生素及抗细菌领域布局制剂及原料药中间体

Ningbo Menovo Pharmaceutical (603538.SH) is laying out the formulation and active pharmaceutical ingredient intermediates in the antibiotics and anti-bacterial fields.

Gelonghui Finance ·  Aug 14 18:34

Ningbo Menovo Pharmaceutical (603538.SH) stated on its investor interaction platform on August 14th that the company is laying out preparations and API in the field of antibiotics and antibacterials, and the moxifloxacin hydrochloride tablets have obtained China pharmaceutical registration certificate in May 2023.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment